Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 13, 2009, Pages 1527-1537

  Mlynarczyk, A ^a   Mlynarczyk, B ^a   Kmera Muszynska, M ^a   Majewski, S ^a   Mlynarczyk, G ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antibiotic resistance; Enterococcus faecalis; Enterococcus faecium; h VISA; MRSA; Plasmids; PRSP; SCCmec; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes; Transposons; VISA; VRE; VRSA

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CEFTAZIDIME; CEFTOBIPROLE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FOSFOMYCIN; FUSIDIC ACID; IMIPENEM; LINEZOLID; MEROPENEM; NOVOBIOCIN; ORITAVANCIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; TEICOPLANIN; TELAVANCIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM POSITIVE BACTERIUM; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PLASMID; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG RESISTANCE, MICROBIAL; GLYCOPEPTIDES; GRAM-POSITIVE COCCI;

EID: 75449112412     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709790361557     Document Type: Short Survey

References (51)

1. Clinical and Laboratory Standards Institute (CLSI) antimicrobial susceptibility testing standards M2-A9 and M7-A7. M100-S18. 2008, 28, 1-181.
2. European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2008 http://www.srga.org/Eucastwt/eucastdefinition.-htm
3. Sandoe, J.A.T.; Wysome, J.; West, A.P.; Heritage, J.; Wileox, M.H. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J. Antimicrob. Chemother., 2006, 57, 767-777.
4. Młynarczyk, A.; Młynarczyk, G. Molecular mechanisms of resistance to antibacterial drugs in Staphylococcus aureus. Post. Mikrobiol., 2008, 47, 423-429.
5. Kernodle, D.S. Mechanisms of resistance to beta-lactam antibiotic. In Gram-positive pathogens. Fischetti, V.A.; Novick, R.P.; Ferretti, J.J.; Portnoy, D.A.; Rood, J.I. Eds. ASM Press: Washington, 2006; pp. 769-781.
6. Fraimow, H.S.; Courvalin, P. Resistance to glycopeptides in Gram-positive pathogens. In Gram-positive pathogens. Fischetti, V.A.; Novick, R.P.; Ferretti, J.J.; Portnoy, D.A.; Rood, J.I. Eds. ASM Press: Washington, 2006; pp. 782-800.
7. McMurry, L.M. Tetracycline resistance determinants in Gram-positive bacteria. In Gram-positive pathogens. V.A. Fischetti; R.P. Novick; J.J. Ferretti; D.A. Portnoy; J.I. Rood Ed.; ASM Press: Washington, 2006; pp. 801-820.
8. Hooper, D.C. Mechanisms of quinolone resistance. In Gram-positive pathogens. Fischetti, V.A.; Novick, R.P.; Ferretti, J.J.; Portnoy, D.A.; Rood, J.I. Eds. ASM Press: Washington, 2006; pp. 821-833.
9. Roberts, MC. Update on acquired tetracycline resistance genes. FEMS Microbiol. Lett. 2005, 2445, 195-203.
10. Młynarczyk, G.; Młynarczyk, A.; Jeljaszewicz, J. Epidemiological aspect of antibiotic resistance in respiratory pathogens. Int. J. Antimicrob. Agents, 2001, 18, 497-502.
11. Jeljaszewicz, J.; Młynarczyk, G.; Młynarczyk, A. Antibiotic resistance in Gram-positive cocci. Int. J. Antimicrob. Agents, 2000, 16, 473-478.
12. European Antimicrobial Resistance Surveillance System (EARSS) Annual Report 1999-2006. Bilthoven, The Netherlands, October 2007.
13. Baba, T.; Bae, T.; Schneewind, O.; Takeuchi, F.; Hiramatsu, K. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J. Bacteriol., 2008, 190, 300-310.
14. Moreillon, P. New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Clin. Microbiol. Infect., 2008, Suppl 3, 32-41.
15. Ito, T.; Okuma, K.; Ma, X.X.; Yuzawa, H.; Hiramatsu, K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug. Res. Updates, 2003, 6, 41-52.
16. Ito, T.; Ma, X.X.; Takeuchi, F.; Okuma, K.; Yuzawa, H.; Hiramatsu, K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob. Agents Chemother., 2004, 48, 2637-2651.
17. Milheirico, C.; Oliveira, D.C.; de Lencastre, H. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: 'SCCmec IV multiplex'. J. Antimicrob. Chemother., 2007, 60, 42-48.
18. Oliveira, D.C.; Milheirico, C.; de Lencastre, H. Redefining a structural variant of staphylococcal cassette chromosome mec, SCCmec type VI. Antimicrob. Agents Chemother., 2006, 50, 3457-3459.
19. Oliveira, D.C.; Milheiriço, C.; Vinga, S.; de Lencastre, H. Assessment of allelic variation in the ccrAB locus in methicillin-resistant Staphylococcus aureus clones. J. Antimicrob. Chemother., 2006, 58, 23-30.
20. Shore, A.; Rossney, A.S.; Keane, C.T.; Enright, M.C.; Coleman, D.C. Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland. Antimicrob. Agents Chemother., 2005, 49, 2070-2083.
21. Chongtrakool, P.; Hiramatsu, K.; Kondo, Y.; Trakulsomboon, S.; Tiensasitorn, C.; Jamklang, M.; Chavalit, T.; Song, J.H.; Hiramatsu, K. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob. Agents Chemother., 2006, 50, 1001-1012.
22. Deurenberg, R.H.; Vink, C.; Kalenic, S.; Friedrich, A.W.; Bruggeman, C.A.; Stobberingh, E.E. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect., 2007, 13, 222-35.
23. Berglund, C.; Ito, T.; Ikeda, M.; Ma, X.X.; Söderquist, B.; Hiramatsu, K. Novel type of staphylococcal cassette chromosome mec in a methicillin-resistant Staphylococcus aureus strain isolated in Sweden. Antimicrob. Agents Chemother., 2008, 52, 3512-3516.
24. Arakere, G.; Nadig, S.; Ito, T.; Ma, X.X.; Hiramatsu, K. A novel type-III staphylococcal cassette chromosome mec (SCCmec) variant among Indian isolates of methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett., 2009, 292, 141-148.
25. El Amin, N.; Lund, B.; Tjernlund, A.; Lundberg, C.; Jalakas, K.; Wretlind, B. Mechanisms of resistance to imipenem in imipenem-resistant, ampicillin-sensitive Enterococcus faecium. APMIS, 2001, 109, 791-796.
26. Mohamed, J.A.; Huang, D.B. Biofilm formation by enterococci. J.Med.Microbiol., 2007, 56, 1581-1588.
27. Chaussee, M.A.; McDowell, E.J.; Rieck, L.D.; Callegari, E.A.; Chaussee, M.S. Proteomic analysis of a penicillin-tolerant rgg mutant strain of Streptococcus pyogenes. J. Antimicrob. Chemother., 2006, 58, 752-759.
28. Pichichero, M.E.; Casey, J.R. Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis. Otolaryngol. Head Neck Surg., 2007,137, 851-857.
29. Steininger, C.; Allerberger, F.; Gnaiger, E. Clinical significance of inhibition kinetics for Streptococcus pyogenes in response to penicillin. J Antimicrob Chemother., 2002, 50, 517-523.
30. Courvalin, P. Vancomycin resistance in Gram-positive cocci. Clin. Infect. Dis., 2006, 42 (Suppl 1), S25-S34.
31. Młynarczyk, G.; Grzybowska, W.; Młynarczyk, A.; Tyski, S.; Kawecki, D.; Łuczak, M.; Durlik, M.; Paczek, L.; Chmura, A.; Rowiński, W. Occurrence of glycopeptide-resistant enterococci in transplant medicine internal wards in 2001-2005. Transplant. Proc., 2007, 39, 2886-2889.
32. Młynarczyk, G.; Grzybowska, W.; Młynarczyk, A.; Tyski, S.; Kawecki, D.; Łuczak, M.; Chmura, A.; Rowiński, W. Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005. Transplant. Proc., 2007, 39, 2883-2885.
33. Novais, C.; Freitas, A.R.; Sousa, J.C.; Baquero, F.; Coque, T.M.; Peixe, L.V. Diversity of Tn1546 and its role in the dissemination of vancomycin-resistant enterococci in Portugal. Antimicrob. Agents Chemother., 2008, 52, 1001-1008.
34. Boyd, D.A.; Willey, B.M.; Fawcett, D.; Gillani, N.; Mulvey, M.R. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob. Agents Chemother., 2008, 52, 2667-2672.
35. Perichon, B.; Courvalin, P. Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 2004, 48, 4281-4285.
36. Zhu, W.; Clark, N.C.; McDougal, L.K.; Hageman, J.; McDonald, L.C.; Patel, J.B. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob. Agents Chemother., 2008, 52, 452-457.
37. Weigel, L.M.; Donlan, R.M.; Shin, D.H.; Jensen, B.; Clark, N.C.; McDougal, L.K.; Zhu, W.; Musser, K.A.; Thompson, J.; Kohlerschmidt, D.; Dumas, N.; Limberger, R.J.; Patel, J.B. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob. Agents Chemother., 2007, 51, 231-238.
38. Dahl, K.H.; Simonsen, G.S.; Olsvik, O.; Sundsfjord, A. Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant Enterococci Antimicrob. Agents Chemother., 1999, 43, 1105-1110.
39. Guardabassi, L.; Dalsgaard, A. Occurrence, structure, and mobility of Tn1546-like elements in environmental isolates of vancomycin-resistant enterococci. Appl. Environ. Microbiol., 2004, 70, 984-990.
40. Boyd, D.A.; Cabral, T.; Van Caeseele, P.; Wylie, J.; Mulvey, M.R. Molecular characterization of the vanE gene cluster in vancomycin-resistant Enterococcus faecalis N00-410 isolated in Canada. Antimicrob. Agents Chemother., 2002, 46, 1977-1979.
41. Fines, M.; Périchon, B.; Reynolds, P.; Sahm, D. F.; Courvalin, P. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob. Agents Chemother., 1999, 43, 2161-2164.
42. Boyd, D.A.; Du, T.; Hizon, R.; Kaplen, B.; Murphy, T.; Tyler, S.; Brown, S.; Jamieson, F.; Weiss, K.; Mulvey, M.R. VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada. Antimicrob. Agents Chemother., 2006, 50, 2217-2221.
43. Depardieu, F.; Bonora, M.G.; Reynolds, P.E.; Courvalin P. The vanG glycopeptide resistance operon from Enterococcus faecalis revisited. Mol. Microbiol., 2003, 50, 931-948.
44. Depardieu, F.; Reynolds, P.E.; Courvalin, P. VanD-type vancomycin-resistant Enterococcus faecium 10/96A. Antimicrob. Agents Chemother., 2003, 47, 7-18.
45. Watanabe, S., Kobayashi, N., Quiñones, D., Hayakawa, S., Nagashima, S., Uehara, N., Watanabe, N. Genetic diversity of the low-level vancomycin resistance gene vanC-2/vanC-3 and identification of a novel vanC subtype (vanC-4) in Enterococcus casseliflavus. Microb. Drug Resist., 2009, 15,1-9.
46. Saha, B.; Singh, A.K.; Ghosh, A.; Bal, M. Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J. Med. Microbiol., 2008, 57, 72-79.
47. Centers for Disease Control and Prevention Vancomycin-resistant Staphylococcus aureus-New York, 2004. MMWR Morb. Mortal. Wkly. Rep., 2004, 53, 322-323.
48. Lamichhane-Khadka, R., Cantore, S.A., Riordan, J.T., Delgado, A., Norman, A.E., Dueñas, S., Zaman, S., Horan, S., Wilkinson, B.J., Gustafson, J.E. sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus. Int. J. Antimicrob. Agents, 2009, 34, 136-141.
49. Van Bambeke, F. Glycopeptides in clinical development: pharmacological profile and clinical perspectives. Curr. Opin. Pharmcol., 2004, 4, 471-478.
50. Jansen, A.; Türck, M.; Szekat, C.; Nagel, M.; Clever, I.; Bierbaum, G. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus. Int. J. Med. Microbiol., 2007, 297, 205-215.
51. Mlynarczyk, G.; Mlynarczyk, A.; Zabicka, D.; Jeljaszewicz, J. Lysogenic conversion as a factor influencing the vancomycin tolerance phenomenon in Staphylococcus aureus. J. Antimicrob. Chemother., 1997, 40, 136-137.